Sector · Aug 2026
Healthcare
What mutual funds hold in Healthcare companies, what they bought and sold, and which fund houses lean on the sector most.
Data periodHoldings monthAug 2026NSE prices25 Sep 2026Data status →
At the end of Aug 2026, mutual funds held ₹4.27 lakh Cr of Healthcare shares across 70 companies — 8.2% of all the equity they disclosed (+0.57 pp on the month).
Funds were estimated net buyers of ₹5,877 Cr: they added to 39 of these companies and cut 31. Over the 12 months to Aug 2026, estimated net buying adds up to +20,279 Cr.
Estimated buying, month by month
Net ₹ crore · same schemes, month-end prices
Loading history…
Share of all fund equity
Per cent of disclosed equity, by value
Loading history…
Value held also moves with the number of fund houses disclosing each month; the share is the steadier guide.
Bought most
Estimated net buying in Aug 2026
- Dr. Reddy's Laboratories Limited30 fund houses₹1,434 Cr
- Fortis Healthcare Limited35 fund houses₹915 Cr
- Dr. Agarwal's Health Care Limited11 fund houses₹838 Cr
- Indegene Limited19 fund houses₹782 Cr
- Zydus Lifesciences Limited33 fund houses₹715 Cr
- Rubicon Research Limited14 fund houses₹712 Cr
- Narayana Hrudayalaya Ltd.22 fund houses₹513 Cr
- Torrent Pharmaceuticals Limited37 fund houses₹511 Cr
Sold most
Estimated net selling in Aug 2026
- Laurus Labs Limited27 fund houses₹1,085 Cr
- Gland Pharma Limited24 fund houses₹582 Cr
- Neuland Laboratories Limited27 fund houses₹281 Cr
- Lupin Limited33 fund houses₹259 Cr
- Glenmark Pharmaceuticals Limited32 fund houses₹243 Cr
- Cohance Lifesciences Limited20 fund houses₹214 Cr
- Divi's Laboratories Limited40 fund houses₹210 Cr
- Viyash Scientific Limited8 fund houses₹202 Cr
Every company funds hold
70 companies · Aug 2026
| Company | Size | Value held | Estimated net buying | Fund houses | Adding | Cutting |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries LimitedSUNPHARMA | Large Cap | 55,980 Cr | +186 Cr | 35 | 128 | 74 |
| Divi's Laboratories LimitedDIVISLAB | Large Cap | 32,872 Cr | -210 Cr | 40 | 75 | 56 |
| Cipla LimitedCIPLA | Large Cap | 22,001 Cr | +89.16 Cr | 35 | 104 | 47 |
| Apollo Hospitals Enterprise LimitedAPOLLOHOSP | Large Cap | 20,160 Cr | +117 Cr | 38 | 110 | 61 |
| Max Healthcare Institute LimitedMAXHEALTH | Large Cap | 18,207 Cr | +202 Cr | 35 | 104 | 41 |
| Aurobindo Pharma LimitedAUROPHARMA | Mid Cap | 15,594 Cr | -134 Cr | 37 | 70 | 37 |
| Torrent Pharmaceuticals LimitedTORNTPHARM | Large Cap | 14,274 Cr | +511 Cr | 37 | 84 | 63 |
| Fortis Healthcare LimitedFORTIS | Mid Cap | 14,200 Cr | +915 Cr | 35 | 78 | 33 |
| Lupin LimitedLUPIN | Mid Cap | 14,025 Cr | -259 Cr | 33 | 80 | 26 |
| Dr. Reddy's Laboratories LimitedDRREDDY | Large Cap | 14,014 Cr | +1,434 Cr | 30 | 93 | 29 |
| IPCA Laboratories LimitedIPCALAB | Mid Cap | 12,306 Cr | -43.01 Cr | 27 | 50 | 19 |
| Gland Pharma LimitedGLAND | Small Cap | 12,120 Cr | -582 Cr | 24 | 48 | 20 |
| Biocon LimitedBIOCON | Mid Cap | 11,784 Cr | +238 Cr | 33 | 76 | 18 |
| Mankind Pharma LimitedMANKIND | Mid Cap | 10,625 Cr | +212 Cr | 30 | 62 | 17 |
| Alkem Laboratories LimitedALKEM | Mid Cap | 10,618 Cr | +286 Cr | 28 | 64 | 16 |
| Aster DM Quality Care LimitedASTERDM | Small Cap | 10,603 Cr | +484 Cr | 28 | 57 | 15 |
| Glenmark Pharmaceuticals LimitedGLENMARK | Mid Cap | 10,422 Cr | -243 Cr | 32 | 67 | 44 |
| Sai Life Sciences LimitedSAILIFE | Small Cap | 8,920 Cr | +35.79 Cr | 24 | 45 | 18 |
| Laurus Labs LimitedLAURUSLABS | Mid Cap | 8,130 Cr | -1,085 Cr | 27 | 65 | 46 |
| Krishna Institute of Medical Sciences LimitedKIMS | Small Cap | 7,505 Cr | -189 Cr | 25 | 33 | 17 |
| Ajanta Pharma LimitedAJANTPHARM | Small Cap | 6,560 Cr | +9.96 Cr | 30 | 49 | 25 |
| Dr. Lal Path Labs Ltd.LALPATHLAB | Small Cap | 5,950 Cr | -29.06 Cr | 30 | 43 | 19 |
| Zydus Lifesciences LimitedZYDUSLIFE | Mid Cap | 5,437 Cr | +715 Cr | 33 | 59 | 31 |
| Global Health LimitedMEDANTA | Mid Cap | 4,978 Cr | +5.02 Cr | 25 | 43 | 16 |
| Syngene International LimitedSYNGENE | Small Cap | 4,269 Cr | +26.50 Cr | 22 | 42 | 11 |
| Anthem Biosciences LimitedANTHEM | Mid Cap | 4,268 Cr | +75.22 Cr | 25 | 44 | 11 |
| Abbott India LimitedABBOTINDIA | Mid Cap | 4,061 Cr | +10.95 Cr | 25 | 36 | 15 |
| Vijaya Diagnostic Centre LimitedVIJAYA | Small Cap | 3,890 Cr | -4.13 Cr | 23 | 28 | 17 |
| Piramal Pharma LimitedPPLPHARMA | Small Cap | 3,699 Cr | -35.08 Cr | 21 | 41 | 8 |
| Metropolis Healthcare LimitedMETROPOLIS | Small Cap | 3,505 Cr | +93.15 Cr | 19 | 13 | 7 |
| Narayana Hrudayalaya Ltd.NH | Mid Cap | 3,354 Cr | +513 Cr | 22 | 39 | 7 |
| Eris Lifesciences LimitedERIS | Small Cap | 3,228 Cr | -114 Cr | 20 | 26 | 7 |
| Neuland Laboratories LimitedNEULANDLAB | Small Cap | 3,135 Cr | -281 Cr | 27 | 28 | 19 |
| Cohance Lifesciences LimitedCOHANCE | Small Cap | 2,909 Cr | -214 Cr | 20 | 35 | 12 |
| Rubicon Research LimitedRUBICON | Small Cap | 2,888 Cr | +712 Cr | 14 | 3 | 10 |
| Pfizer LimitedPFIZER | Small Cap | 2,804 Cr | +55.54 Cr | 22 | 25 | 5 |
| Rainbow Childrens Medicare LimitedRAINBOW | Small Cap | 2,678 Cr | +27.55 Cr | 22 | 30 | 11 |
| Acutaas Chemicals LimitedACUTAAS | Small Cap | 2,628 Cr | -1.96 Cr | 26 | 44 | 22 |
| GlaxoSmithKline Pharmaceuticals LimitedGLAXO | Mid Cap | 2,484 Cr | +243 Cr | 23 | 44 | 12 |
| Onesource Specialty Pharma LimitedONESOURCE | Small Cap | 2,257 Cr | -25.18 Cr | 21 | 29 | 6 |
| Dr. Agarwal's Health Care LimitedAGARWALEYE | Small Cap | 2,255 Cr | +838 Cr | 11 | 13 | 2 |
| Thyrocare Technologies LimitedTHYROCARE | Small Cap | 2,196 Cr | +396 Cr | 15 | 11 | 6 |
| Healthcare Global Enterprises LimitedHCG | Small Cap | 1,912 Cr | +120 Cr | 12 | 6 | 4 |
| Wockhardt LimitedWOCKPHARMA | Small Cap | 1,765 Cr | -121 Cr | 20 | 33 | 9 |
| Poly Medicure LimitedPOLYMED | Small Cap | 1,759 Cr | +43.21 Cr | 19 | 26 | 8 |
| Indegene LimitedINDGN | Small Cap | 1,689 Cr | +782 Cr | 19 | 26 | 5 |
| Emcure Pharmaceuticals LimitedEMCURE | Small Cap | 1,672 Cr | -33.72 Cr | 19 | 23 | 7 |
| CORONA Remedies LimitedCORONA | Small Cap | 1,486 Cr | -15.24 Cr | 12 | 3 | 4 |
| Jupiter Life Line Hospitals LimitedJLHL | Small Cap | 1,305 Cr | +11.26 Cr | 15 | 9 | 2 |
| Sanofi Consumer Healthcare India LimitedSANOFICONR | Small Cap | 1,234 Cr | -1.88 Cr | 15 | 2 | 3 |
| Alembic Pharmaceuticals LimitedAPLLTD | Small Cap | 1,127 Cr | +4.85 Cr | 12 | 9 | 3 |
| Jubilant Pharmova LimitedJUBLPHARMA | Small Cap | 1,062 Cr | +97.40 Cr | 19 | 28 | 6 |
| Alivus Life Sciences LimitedALIVUS | Small Cap | 938 Cr | -12.02 Cr | 12 | 4 | 3 |
| Strides Pharma Science LimitedSTAR | Small Cap | 926 Cr | +80.57 Cr | 8 | 4 | 2 |
| Akums Drugs and Pharmaceuticals LimitedAKUMS | Small Cap | 924 Cr | -76.99 Cr | 10 | 3 | 6 |
| Concord Biotech LimitedCONCORDBIO | Small Cap | 892 Cr | +244 Cr | 19 | 23 | 6 |
| Granules India LimitedGRANULES | Small Cap | 810 Cr | +46.90 Cr | 22 | 37 | 10 |
| Shilpa Medicare LimitedSHILPAMED | Small Cap | 787 Cr | -8.15 Cr | 12 | 7 | 6 |
| Yatharth Hospital & Trauma Care Services LimitedYATHARTH | Small Cap | 469 Cr | +7.88 Cr | 6 | 6 | 4 |
| Blue Jet Healthcare LimitedBLUEJET | Small Cap | 429 Cr | +2.96 Cr | 14 | 22 | 6 |
| Marksans Pharma LimitedMARKSANS | Small Cap | 413 Cr | -19.72 Cr | 9 | 7 | 5 |
| Aarti Drugs LimitedAARTIDRUGS | Small Cap | 379 Cr | -0.08 Cr | 7 | 1 | 2 |
| Caplin Point Laboratories LimitedCAPLIPOINT | Small Cap | 326 Cr | -33.26 Cr | 16 | 25 | 11 |
| Natco Pharma LimitedNATCOPHARM | Small Cap | 277 Cr | -4.46 Cr | 19 | 36 | 11 |
| Viyash Scientific LimitedVIYASH | Small Cap | 233 Cr | -202 Cr | 8 | 4 | 4 |
| Supriya Lifescience LimitedSUPRIYA | Small Cap | 62.53 Cr | -0.81 Cr | 8 | 4 | 3 |
| Advanced Enzyme Technologies LimitedADVENZYMES | Small Cap | 55.69 Cr | -4.50 Cr | 8 | 2 | 3 |
| Aarti Pharmalabs LimitedAARTIPHARM | Small Cap | 43.49 Cr | -12.78 Cr | 9 | 4 | 2 |
| Park Medi World LimitedPARKHOSPS | Small Cap | 36.14 Cr | +0.12 Cr | 6 | 3 | 2 |
| Sun Pharma Advanced Research Company LimitedSPARC | Small Cap | 5.96 Cr | +0.06 Cr | 6 | 4 | 2 |
Fund houses that lean on Healthcare
Share of each fund house’s disclosed equity in this sector · all funds: 8.2%
| Fund house | Share of its equity | Versus all funds | Value held | Companies |
|---|---|---|---|---|
| Capitalmind Mutual Fund | 23.6% | +15.44 pp | 121 Cr | 11 |
| NJ Mutual Fund | 22.1% | +13.97 pp | 1,515 Cr | 23 |
| Old Bridge Mutual Fund | 13.9% | +5.74 pp | 636 Cr | 12 |
| quant Mutual Fund | 13.4% | +5.20 pp | 11,435 Cr | 18 |
| WhiteOak Capital Mutual Fund | 12.4% | +4.20 pp | 4,164 Cr | 38 |
| Invesco Mutual Fund | 12.0% | +3.84 pp | 14,144 Cr | 28 |
| Bajaj Finserv Mutual Fund | 11.8% | +3.67 pp | 2,655 Cr | 27 |
| Samco Mutual Fund | 11.8% | +3.63 pp | 250 Cr | 23 |
| HDFC Mutual Fund | 11.2% | +3.05 pp | 70,375 Cr | 56 |
| Axis Mutual Fund | 10.9% | +2.71 pp | 23,457 Cr | 55 |
| Mirae Asset Mutual Fund | 10.8% | +2.63 pp | 20,783 Cr | 70 |
| Bank of India Mutual Fund | 10.3% | +2.18 pp | 1,363 Cr | 21 |
Fund houses with at least ₹1 crore in the sector. A high share reflects the fund house’s scheme mix (sector and thematic funds) as much as a view.
Sector: NSE Indices industry classification. Values: disclosed quantities × official NSE closing prices. Estimates are not transaction records. Method →